Neela Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for Hippocampal drug delivery devices and methods (US 10,300,251) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 1 fee due Jan 30, 2027The maintenance fee for Systems and methods for reducing or preventing backflow in a delivery system (US 10,363,394) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
- 1 fee due Mar 10, 2027The maintenance fee for Drug delivery systems and methods (US 10,406,285) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
- 3 fees due Apr 8 to 29, 2027 · next Apr 8
- 1 fee due Jun 26, 2027The maintenance fee for Therapy specific, pre-programmed auto injection device (US 11,850,374) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,137,244 | Microfluidic drug delivery devices with venturi effect In force · From the USPTO record | In force | From the USPTO record | |
| US 10,434,251 | Multi-directional microfluidic drug delivery device In force · From the USPTO record | In force | From the USPTO record | |
| US 8,992,458 | Systems and Methods for Reducing or Preventing Backflow in a Delivery System In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,363,394 | Systems and methods for reducing or preventing backflow in a delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 10,456,533 | Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters In force · From the USPTO record | In force | From the USPTO record | |
| US 11,213,653 | Systems and methods for reducing or preventing backflow in a delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 10,065,016 | Systems and methods for reducing or preventing backflow in a delivery system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,919,129 | Systems and Methods for Reducing or Preventing Backflow in a Delivery System In force · High confidence | In force | High confidence | |
| US 11,534,592 | Systems and Methods for Drug Delivery, Treatment, and Monitoring In force · Medium confidence | In force | Medium confidence | |
| US 10,406,285 | Drug delivery systems and methods In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.